Scripps MD Anderson Cancer Center Clinical Hematology and Oncology 2024

40 $

+ Include: 39 videos + 1 pdf, size: 13.4 GB

+ Target Audience: hematologist, oncologist, surgeon, radiation oncologist, internist

Description

+ Include: 39 videos + 1 pdf, size: 13.4 GB

+ Target Audience: hematologist, oncologist, surgeon, radiation oncologist, internist

+ Sample video: contact me for sample video

+ Information:

Course Overview
The Scripps Clinical Hematology and Oncology conference is designed for hematologists, oncologists, surgeons, radiation oncologists, internists, and others desiring an update in these specialty areas. The primary objective of this course is to bring together clinicians and leading experts in diverse areas of hematology and oncology, affording them an intimate environment in which to discuss new clinical developments and significant advances. Our annual program is a nationally accredited continuing medical education conference and is one of the largest annual hematology/oncology meeting held in the West, among others such as ASH, ASCO and the San Antonio Breast Meeting. This conference is one of the few that combines topics in both hematology and oncology.

Educational Objectives
After attending this live activity, participants should be able to:
• Describe the clinical and molecular facets of pathogenesis, diagnostic approaches, and therapeutic modalities available for various hematologic disorders.
• Select and apply the changing approaches to hematologic malignancies, particularly as they relate to evidence-based standards of care, including innovations in diagnosis and treatment.
• Choose new therapeutic options for the treatment of several common malignancies, understanding appropriate indications and contraindications to these therapeutic approaches.
• Integrate evolving approaches to solid tumors and breast cancer from both a diagnostic, prognostic, and therapeutic perspective.
• Apply practical expertise gained from the clinical situations discussed in the panel sessions with an emphasis on data-based approaches to patients with common, but serious hematology oncology conditions.

Target Audience
• Hematologists/Oncologists
• Medical Oncologists
• Surgeons
• Radiation Oncologists
• Internists
• And others desiring an update in these specialty areas

 

+ Topics:

brochure_hemonc24_compressed2.pdf
BREAST CANCER, NEURO-ONCOLOGY AND MELANOMA Anthracyclines in Early Breast Cancer Do They Still Have a Role.mp4
BREAST CANCER, NEURO-ONCOLOGY AND MELANOMA Breast Cancer in Pregnancy.mp4
BREAST CANCER, NEURO-ONCOLOGY AND MELANOMA CDK4 6 Inhibitor Therapy in Early-stage HR+ HER2- Breast Cancer.mp4
BREAST CANCER, NEURO-ONCOLOGY AND MELANOMA Combination Immunotherapy in Melanoma.mp4
BREAST CANCER, NEURO-ONCOLOGY AND MELANOMA Neuro-Oncology 2024 Update.mp4
BREAST CANCER, NEURO-ONCOLOGY AND MELANOMA Panel Discussion Q&A 1.mp4
BREAST CANCER, NEURO-ONCOLOGY AND MELANOMA Panel Discussion Q&A 2.mp4
BREAST CANCER, NEURO-ONCOLOGY AND MELANOMA Sequencing Therapies in Metastatic Urothelial Carcinoma.mp4
Concurrent Breakout Sessions Clinical Cases Breakout 1 Interesting Cases in Thrombosis.mp4
Concurrent Breakout Sessions Clinical Cases Breakout 2 Interesting Cases in Platelet Disorders.mp4
Concurrent Breakout Sessions Clinical Cases Breakout 3 Interesting Cases in Bleeding.mp4
Concurrent Breakout Sessions Clinical Cases Breakout 4 Interesting Cases in Plasma Cell Dyscrasias.mp4
GI AND GYN CANCERS GI AND GYN CANCERS Artificial Intelligence in Oncology.mp4
GI AND GYN CANCERS GI AND GYN CANCERS Integrating Immunotherapy into the Treatment of Cervical and Endometrial Cancers.mp4
GI AND GYN CANCERS GI AND GYN CANCERS New Approaches to Recurrent or Metastatic Ovarian Cancer.mp4
GI AND GYN CANCERS GI AND GYN CANCERS Panel Discussion Q&A.mp4
GI AND GYN CANCERS GI AND GYN CANCERS Perioperative Therapy of Resectable Non-small Cell Lung Cancer.mp4
GI AND GYN CANCERS GI AND GYN CANCERS Using ctDNA to Drive Decision Making in Adjuvant Chemotherapy of Colon Cancer.mp4
GI AND GYN CANCERS Panel Discussion Q&A.mp4
GI AND GYN CANCERS Perioperative Therapy of Resectable Non-small Cell Lung Cancer.mp4
MALIGNANT HEMATOLOGY Advances in Frontline Treatment of FLT3-mutated AML.mp4
MALIGNANT HEMATOLOGY BTK Refractory CLL.mp4
MALIGNANT HEMATOLOGY Detangling New Approaches to Hairy Cell Leukemia A Comb or a Brush.mp4
MALIGNANT HEMATOLOGY Management of MDS AML in the Geriatric Patient.mp4
MALIGNANT HEMATOLOGY Myeloproliferative Neoplasms 2024 Update.mp4
MALIGNANT HEMATOLOGY NON-HODGKIN LYMPHOMAS Frontline Treatment of DLBCL.mp4
MALIGNANT HEMATOLOGY NON-HODGKIN LYMPHOMAS Management of Indolent NHL.mp4
MALIGNANT HEMATOLOGY NON-HODGKIN LYMPHOMAS Panel Discussion Q&A.mp4
MALIGNANT HEMATOLOGY NON-HODGKIN LYMPHOMAS Updates in the Treatment of Relapsed DLBCL.mp4
MALIGNANT HEMATOLOGY Panel Discussion Q&A 1.mp4
MALIGNANT HEMATOLOGY Panel Discussion Q&A 2.mp4
MALIGNANT HEMATOLOGY Smoldering Multiple Myeloma.mp4
NON-MALIGNANT HEMATOLOGY Heavy Menstrual Bleeding- Workup for Bleeding Disorder and Management.mp4
NON-MALIGNANT HEMATOLOGY Hemolytic Anemias-Autoimmune, Membrane and Enzyme Defects.mp4
NON-MALIGNANT HEMATOLOGY Management of Autoimmune, Viral and Surgical-associated Anti-PF4 Disorders.mp4
NON-MALIGNANT HEMATOLOGY Management of Hematologic Conditions in Athletes.mp4
NON-MALIGNANT HEMATOLOGY Management of Simultaneous Venous and Arterial Thromboembolic Disease.mp4
NON-MALIGNANT HEMATOLOGY Panel Discussion Q&A.mp4
NON-MALIGNANT HEMATOLOGY Thrombosis 2024 Update.mp4

Reviews

There are no reviews yet.

Be the first to review “Scripps MD Anderson Cancer Center Clinical Hematology and Oncology 2024”

Your email address will not be published. Required fields are marked *